Monster Beverage looks like a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to deploy. The stock has supportive analyst revisions, constructive technicals, and a favorable congress buy signal, while the current pre-market dip offers a workable entry. I would classify it as a buy now rather than waiting for a perfect pullback.
MNST is in a short-term uptrend with bullish moving averages (SMA_5 > SMA_20 > SMA_200), which is a positive sign for trend continuation. MACD histogram is above zero at 0.173, though it is contracting, suggesting momentum is still positive but cooling a bit. RSI_6 at 62.572 is neutral-to-bullish and not overbought. Price is near the pivot at 87.431, with resistance at 89.208 and 90.305 and support at 85.655 and 84.558. Overall, the chart structure supports an acceptable long-term entry.

Analysts have recently turned more constructive, with multiple price target hikes and several Buy/Outperform ratings after a very strong Q1 and April update. Morgan Stanley called the growth profile unique and more durable, while Deutsche Bank said the company is firing on all cylinders. Congress trading data is positive with one recent purchase and no sales, indicating supportive sentiment from that group. The stock also benefits from Monster’s long-term exposure to global energy drink growth and the Coca-Cola distribution system.
Hedge funds are reported as selling aggressively, and insiders are also net sellers, which is the clearest negative signal in the dataset. Options open interest still shows slightly more puts than calls, implying some caution in the market. The pre-market price is slightly down, so near-term enthusiasm is not fully uniform even though the larger trend remains positive.
Latest quarter financials are not fully provided, but the available analyst commentary says Q1 and April results were very strong, with revenue growth and top-line performance exceeding expectations. This implies the latest reported quarter was likely a strong growth quarter for Monster Beverage, and analysts have raised FY26 EPS estimates to reflect the beat and improved near-term trends.
Analyst sentiment is positive and improving. Recent actions include Morgan Stanley raising its target to $100 and keeping Overweight, BofA raising to $99 and keeping Buy, Deutsche Bank raising to $94 and keeping Buy, Evercore raising to $95 and keeping Outperform, and Rothschild upgrading to Buy with a target of $90. Neutral views from UBS and JPMorgan remain, but even they raised targets. Wall Street’s pros mostly see durable growth, strong international performance, and a favorable demand backdrop; the main con is that some firms still view the stock as fairly valued or only Neutral.